Dr. Doron Schneider and Dr. Jack Leahy discuss what the DCCT and EDIC trials found regarding type 2 diabetes.

DCCT and EDIC: Implications for Type 2 Diabetes

The Beta Cells in Diabetes podcast seeks to improve understanding among primary care physicians about the role of beta cells as key drivers in the development and progression of T2DM.  Our goal is to engage primary care physicians in pathopysiology-based clinical decision making through an interactive educational format that stimulates debate and encourages physicians to incorporate the new science into their patient treatment regimens.   By educating primary care physicians about the newest findings regarding beta cell treatment, we hope to positively affect the diabetes epidemic.

Medicine

The Beta Cells in Diabetes podcast seeks to improve understanding among primary care physicians about the role of beta cells as key drivers in the development and progression of T2DM. Our goal is to engage primary care physicians in pathopysiology-based clinical decision making through an interactive educational format that stimulates debate and encourages physicians to incorporate the new science into their patient treatment regimens. By educating primary care physicians about the newest findings regarding beta cell treatment, we hope to positively affect the diabetes epidemic.

Share DCCT and EDIC: Implications for Type 2 Diabetes

Sign up to save your podcasts

DCCT and EDIC: Implications for Type 2 Diabetes

DCCT and EDIC: Implications for Type 2 Diabetes